There are 1076 resources available
117TiP - Safety and efficacy of reduced-port laparoscopic surgery for patients with colon and upper rectal cancer: A multicenter, prospective, randomized phase III study
Presenter: Zhimin Liu
Session: Poster Display session
Resources:
Abstract
118TiP - Neoadjuvant CAPOX plus SCT510 (bevacizumab biosimilar) and finotonlimab in high-risk resectable colorectal liver metastases (CRLM): A multicenter, phase II study
Presenter: Wensheng Qiu
Session: Poster Display session
Resources:
Abstract
119TiP - A randomized, controlled, multicenter phase III study of IBI310 (anti-CTLA-4 antibody) plus sintilimab (anti-PD-1 antibody) as neoadjuvant treatment for resectable microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) colon cancer
Presenter: Rui-Hua Xu
Session: Poster Display session
Resources:
Abstract
120TiP - Neoadjuvant short-course radiotherapy combined with chemotherapy and cadonilimab for patients with locally advanced rectal cancer: A prospective, single-arm phase II trial
Presenter: Jiawei Rao
Session: Poster Display session
Resources:
Abstract
121TiP - Comparison of postoperative anal function between parks and bacon techniques in lower rectal cancer: A multicenter, prospective, randomized control study
Presenter: Zhimin Liu
Session: Poster Display session
Resources:
Abstract
122TiP - Watch and wait in patients with DNA mismatch repair-deficient or microsatellite instability-high distal rectal cancer accessed pathological complete response after PD-1 monoclonal antibody therapy (BASKET)
Presenter: Fang He
Session: Poster Display session
Resources:
Abstract
123TiP - Dynamic multi-omics integration modelto predict neoadjuvant therapy response in locally advanced rectal cancer
Presenter: Yandong Zhao
Session: Poster Display session
Resources:
Abstract
124TiP - Safety and efficacy of PD-1 monoclonal antibody with or without mFOLFOX6 neoadjuvant therapy in patients with local advanced deficient mismatch repair/microsatellite instability-high synchronous multiple primary colorectal cancer
Presenter: Yandong Zhao
Session: Poster Display session
Resources:
Abstract
125TiP - Prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) for locally advanced colorectal cancer: A single-centre, open-label, randomized controlled trial
Presenter: Shiyu Xu
Session: Poster Display session
Resources:
Abstract
135P - Three-year survival, safety and extended long-term survivor (eLTS) analysis from the phase III TOPAZ-1 study of durvalumab (D) plus chemotherapy in advanced biliary tract cancer (aBTC)
Presenter: Do-Youn Oh
Session: Poster Display session
Resources:
Abstract